Top compounds associated with response to POMZP3


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC -0.15 0.01
mRNA pluripotin CTRPv2 pan-cancer AAC -0.093 0.01
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.1 0.01
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.01
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.01
mRNA SNS-032 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA prima-1 CTRPv2 pan-cancer AAC 0.08 0.01
mRNA RAF265 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.01
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.092 0.01
Download CSV